Active Compound Combination
Patent Information
- Application Number
- JP2022577793
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-06-18
- Filing Date
- 2021-06-16
- Publication Date
- 2025-09-01
- Estimated Expiration
- 2041-06-16
Smart Images

Figure 0007731917000001 
Figure 0007731917000002 
Figure 0007731917000003
Abstract
Claims
1. (A) Formula (I) 【Chemical 1】 at least one compound of the formula A is O; m is 1; T is hydrogen; R 3 and R 4 is hydrogen; R 5 is hydrogen; L is methylene; R 6 is 2,4-dimethylphenyl, 2-methyl-4-bromophenyl, or 2-chloro-4-methylphenyl; R 7 is methyl; R 8 is hydrogen; Q is 2-fluoro-3-chlorophenyl, 2-fluoro-3-bromophenyl, or 2-fluoro-3-cyclopropylphenyl; (B) at least one further active compound, (1.002) Difenoconazole, (1.018) Prothioconazole, (1.020) Spiroxamine, (1.021) Tebuconazole, (1.055) Mefentrifluconazole, (1.062) Fluoxythioconazole, (1.067) N'-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methylimidoformamide, (1.092) Methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1,2,4-triazol-1-yl)propanoate, (2.001) Benzovindiflupyr, (2.002) Bixafen, (2.003) Boscalid, (2.005) Fluopyram, (2.007) Fluxapyroxad, (2.009) Isofetamide, (2.017) Penflufen, (2.019) Pydiflumetofen, (2.028) Inpirfluxam, (2.030) Fluindapyr, (2.038) Isoflucipram, (3.012) Fluoxastrobin, (3.020) Trifloxystrobin, (3.025) Fenpicoxamide, (3.030) Methyltetraprole, (3.031) Florylpicoxamide, (3.032) (2S,3S)-3-(o-Tolyl)butan-2-yl N-{[4-methoxy-3-(propanoyloxy)-2-pyridyl]carbonyl}-L-alaninate, (5.003) Captan, (5.010) Dithianon, (5.012) Folpet, (5.013) Mancozeb, (5.018) Propineb, (6.002) Isotianil, (7.005) Pyrimethanil, (12.004) Metalaxyl-M (mefenoxam), (13.001) Fludioxonil, (13.004) Proquinazid, (13.005) Quinoxyfen, (15.012) Fosetylaluminum, (15.016) Metrafenone, (15.041) ipflufenoquine, (15.043) fluoxapiprolin, and (15.064) (N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methylimidoformamide), (17.001) Bacillus subtilis, strain QST713 / AQ713 (available from Bayer CropScience LP, USA, as SERENADE OPTI® or SERENADE ASO®, having NRRL accession number B21661 and described in U.S. Pat. No. 6,060,051), (17.012) a strain of Paenibacillus sp., having NRRL accession number B-50972 or NRRL accession number B-50973, B-67129 and those described in International Publication No. WO 2016 / 154297, and (18.001) a composition comprising one or more fatty acids selected from unsaturated and saturated C 12 -C 24 fatty acids, their salts, or mixtures of any of the foregoing, wherein at least 95% of the fatty acids are in the C 14 to C 20 range (available as FLiPPER from AlphaBio Pesticides or Bayer AG), and at least one further active compound selected from the group consisting of 10. An active compound combination comprising:
2. The compound of formula (I) is (I-052) rac-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2,4-dimethylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine, (I-130) (5S)-3-[3-(3-cyclopropyl-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2,4-dimethylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine, (I-300) rac-5-[(4-bromo-2-methylphenyl)methyl]-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine, (I-302) rac-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine, (I-337) (5S)-5-[(4-bromo-2-methylphenyl)methyl]-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5,6-dihydro-4H-1,2,4-oxadiazine, (I-338) 2. The active compound combination according to claim 1, wherein the active compound is selected from the group consisting of (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine and (I-339) (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine.
3. The compound of formula (I) is (I-302) rac-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-[(2-chloro-4-methylphenyl)methyl]-5,6-dihydro-4H-1,2,4-oxadiazine, (I-338) (5R)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine, and (I-339) 3. The active compound combination according to claim 1, which is selected from the group consisting of (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine.
4. An active compound combination according to any one of claims 1 to 3, wherein the compound of formula (I) is (I-339) (5S)-3-[3-(3-chloro-2-fluorophenoxy)-6-methylpyridazin-4-yl]-5-(2-chloro-4-methylbenzyl)-5,6-dihydro-4H-1,2,4-oxadiazine.
5. The further active compound (B) is (1.002) difenoconazole, (1.018) prothioconazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.055) mefentrifluconazole, (1.062) fluoxythioconazole, (1.092) methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1,2,4-triazol-1-yl)propanoate, (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.005) fluopyram, (2.007) fluxapyroxad, (2.009) isofetamide, (2.017) Penflufen, (2.019) Pydiflumetofen, (2.028) Inpirfluxam, (2.030) Fluindapyr, (2.038) Isoflucipram, (3.012) Fluoxastrobin, (3.020) Trifloxystrobin, (3.025) Fenpicoxamide, (3.030) Methyltetraprole, (3.031) Florylpicoxamide, (3.032) (2S,3S)-3-(o-tolyl)butan-2-yl N-{[4-methoxy-3-(propanoyloxy)-2-pyridyl]carbonyl}-L-alaninate, (5.018) Propineb, (7.005) Pyrimethanil, (12.004) 5. The active compound combination according to any one of claims 1 to 4, selected from the group consisting of metalaxyl-M (mefenoxam), (13.001) fludioxonil, (13.004) proquinazid, (15.012) fosetylaluminum, (15.016) metrafenone, and (15.043) fluoxapiproline.
6. The further active ingredient (B) is (1.002) difenoconazole, (1.018) prothioconazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.055) mefentrifluconazole, (1.062) fluoxythioconazole, (1.092) methyl 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1,2,4-triazol-1-yl)propanoate, (2.002) bixafen, (2.005) fluopyram, (2.007) fluxapyroxad, (2.009) isofetamide, (2.019) pydiflumetofen, (2.028) inpirfluxam, (2.038) 6. The active compound combination according to any one of claims 1 to 5, selected from the group consisting of isoflucipram, (3.020) trifloxystrobin, (3.025) fenpicoxamide, (3.030) methyltetraprole, (3.031) flurylpicoxamide, and (3.032) (2S,3S)-3-(o-tolyl)butan-2-yl N-{[4-methoxy-3-(propanoyloxy)-2-pyridyl]carbonyl}-L-alaninate.
7. A composition for controlling phytopathogenic harmful fungi in crop protection and material protection, characterized by the inclusion of an active compound combination as defined in any one of claims 1 to 6 in addition to one or more fillers and / or surfactants.
8. 10. A method for controlling phytopathogenic harmful fungi in crop protection and material protection, characterized in that an active compound combination according to at least one of claims 1 to 6 or a composition according to claim 7 is applied to the phytopathogenic harmful fungi and / or their habitat.
9. 10. Use of an active compound combination according to at least one of claims 1 to 6 or a composition according to claim 7 for controlling phytopathogenic harmful fungi in crop protection and material protection.
10. 8. Use of an active compound combination according to at least one of claims 1 to 6 or a composition according to claim 7 for treating transgenic plants.
11. 8. Use of an active compound combination according to at least one of claims 1 to 6 or a composition according to claim 7 for treating seeds.
12. Use of an active compound combination according to at least one of claims 1 to 6 or a composition according to claim 7 for treating seeds of transgenic plants.
13. Seeds coated with an active compound combination according to at least one of claims 1 to 6 or with a composition according to claim 7.
Citation Information
Patent Citations
Agricultural and horticultural fungicide
JP1980007250A
Microbicide
JP1993255311A
Methoxyiminomethyloxadiazine used as a pest control agent
JP2001515076A
Dioxazine-Substituted Arylamides and Oxadiazine-Substituted Arylamides
JP2009512629A
Tetrazolinone compound, and use therefor
WO2015016372A1